SCHEMBL51596

SCHEMBL51596

CCCCCCCCOS(=O)(=O)[O-].CCCCn1cc[n+](C)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.60
MEN1 O00255 2/20 0.60
HSP90AA1 P07900 2/20 0.60
KMT2A Q03164 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
APAF1 O14727 1/20 0.60
NPC1 O15118 1/20 0.60
PLA2G1B P04054 1/20 0.60
MAPT P10636 1/20 0.60
HTT P42858 1/20 0.60
RAB9A P51151 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
ATG4B Q9Y4P1 1/20 0.60
RECQL P46063 2/20 0.54
GLA P06280 1/20 0.54
HPGD P15428 1/20 0.54
TSHR P16473 1/20 0.54
EPHX2 P34913 1/20 0.54
BLM P54132 1/20 0.54
CA1 P00915 8/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1416525 1.00 MAPK1 (0.60) MAPK1MEN1HSP90AA1KMT2ASMN1; SMN2
SCHEMBL20185647 1.00 MAPK1 (0.60) MAPK1MEN1HSP90AA1KMT2ASMN1; SMN2
Amylosulfuric Acid SCHEMBL5486551 0.99 MAPK1 (0.57) MAPK1MEN1HSP90AA1KMT2ASMN1; SMN2
SCHEMBL28567948 0.97 MAPK1 (0.64) MAPK1MEN1HSP90AA1KMT2ASMN1; SMN2
SCHEMBL1416690 0.97 MAPK1 (0.64) MAPK1MEN1HSP90AA1KMT2ASMN1; SMN2
SCHEMBL1416563 0.97 MAPK1 (0.64) MAPK1MEN1HSP90AA1KMT2ASMN1; SMN2
SCHEMBL1416736 0.97 MAPK1 (0.64) MAPK1MEN1HSP90AA1KMT2ASMN1; SMN2
SCHEMBL1416692 0.97 MAPK1 (0.64) MAPK1MEN1HSP90AA1KMT2ASMN1; SMN2
SCHEMBL5961696 0.97 MAPK1 (0.64) MAPK1MEN1HSP90AA1KMT2ASMN1; SMN2
SCHEMBL1416670 0.97 MAPK1 (0.64) MAPK1MEN1HSP90AA1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 574 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12172147-B2 Catalyst composition for selective hydrogenation with improved characteristics Sud Chemie, Inc. (US) 2024-12-24 US claimed
US-12172148-B2 Catalyst composition for selective hydrogenation with improved characteristics Sud Chemie, Inc. (US) 2024-12-24 US claimed
CN-116075500-B Capacitor with improved capacitance 基美电子公司 2024-11-26 CN claimed
US-20240336833-A1 POLYCANNABINOIDS FOR COMMODITY POLYMERS AND COMMODITY ELECTRONICS UNIVERSITY OF CONNECTICUT 2024-10-10 US claimed
US-20240337641-A1 STRAIN SENSOR FOR MONITORING PLANT ELONGATION THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2024-10-10 US claimed
EP-3470493-B1 COMPOSITIONS COMPRISING LATENT HEAT STORAGE MATERIALS PHASE CHANGE ENERGY SOLUTIONS INC (US) 2024-05-15 EP claimed
US-11932813-B2 Electrochromic materials; preparation and use thereof UNIVERSITY OF CONNECTICUT (US) 2024-03-19 US claimed
US-20230159749-A1 STRETCHABLE ELECTROCONDUCTIVE MATERIAL, METHOD FOR MANUFACTURING THE SAME, AND DEVICE USING THE STRETCHABLE ELECTROCONDUCTIVE MATERIAL Zhen Ding Technology Co., Ltd. (TW) 2023-05-25 US claimed
CN-116075500-A Capacitor with improved capacitance 基美电子公司 2023-05-05 CN claimed
US-11634370-B2 Selective hydrogenation methods CLARIANT INTERNATIONAL LTD (CH) 2023-04-25 US claimed
US-20070034513-A1 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array COMBIMATRIX CORPORATION 2007-02-15 US claimed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO claimed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO claimed
WO-2006122563-A1 A PROCESS FOR CONTINUOUS CARBONYLATION BY SUPPORTED IONIC LIQUID-PHASE CATALYSIS DANMARKS TEKNISKE UNIVERSITET (DK) 2006-11-23 WO claimed
US-20060203322-A1 Gel polymers containing ionic liquids ARMY, UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF THE 2006-09-14 US claimed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US claimed
US-6995293-B2 Method for the production of aldehydes CELANESE CHEMICALS EUROPE GMBH (DE) 2006-02-07 US claimed
US-20050175894-A1 Prevents the active metal from deleterious reaction with the environment on the other (cathode) side of the impervious layer, which may include aqueous or non-aqueous liquid electrolytes (catholytes) and/or a variety electrochemically active materials, including liquid, solid and gaseous oxidizers POLYPLUS BATTERY COMPANY 2005-08-11 US claimed
US-20050085671-A1 Method for the production of aldehydes DRACHENFELSSEE 521. VV GMBH (TO BE RENAMED OXEA DEUTSCHLAND GMBH) (DE) 2005-04-21 US claimed
US-20040191617-A1 Chemical resistance; anodes, cathodes; protective membrane coating POLYPLUS BATTERY COMPANY 2004-09-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12172147-B2 Catalyst composition for selective hydrogenation with improved characteristics BET1, EP300, H1-2 MAPK1 3595/4885MEN1 2422/4885HSP90AA1 3150/4885
US-12172148-B2 Catalyst composition for selective hydrogenation with improved characteristics BET1, EP300, H1-2 MAPK1 3595/4885MEN1 2422/4885HSP90AA1 3150/4885
US-11634370-B2 Selective hydrogenation methods KAT8, KAT7, TDO2 MAPK1 2359/4885MEN1 3450/4885HSP90AA1 958/4885
US-20050085671-A1 Method for the production of aldehydes ACSL3, ACSL5, TST MAPK1 4203/4885MEN1 3675/4885HSP90AA1 2961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.